VistaGen Therapeutics, Inc.VTGNNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-55.34M
↓ 86% below average
Average (9y)
$-29.80M
Historical baseline
Range
High:$-9.77M
Low:$-58.74M
CAGR
+13.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-55.34M | -70.5% |
| 2024 | $-32.45M | +44.7% |
| 2023 | $-58.74M | -24.8% |
| 2022 | $-47.05M | -169.8% |
| 2021 | $-17.44M | +15.6% |
| 2020 | $-20.65M | +15.6% |
| 2019 | $-24.47M | -71.6% |
| 2018 | $-14.25M | -45.9% |
| 2017 | $-9.77M | +45.1% |
| 2016 | $-17.80M | - |